Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lankester

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
The Journal of Allergy and Clinical Immunology|May 25, 2021
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndromeDimana Dimitrova, Zohreh Nademi, Maria Elena Maccari, et al.
The Journal of Allergy and Clinical Immunology|October 31, 2021
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortArjan C Lankester, Benedicte Neven, Nizar Mahlaoui, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2019
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC studyFrancesca Ferrua, Stefania Galimberti, Virginie Courteille, et al.
Blood|July 1, 2020
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiencySujal Ghosh, Sevgi Köstel Bal, Emily S J Edwards, et al.
Blood|March 28, 2022
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP studyMichael H Albert, Tiarlan Sirait, Dirk-Jan Eikema, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITAPeter Olbrich, M Fischer, A Deyà-Martinez, et al.
The Journal of Allergy and Clinical Immunology|May 25, 2021
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndromeDimana Dimitrova, Zohreh Nademi, Maria Elena Maccari, et al.
The Journal of Allergy and Clinical Immunology|October 31, 2021
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortArjan C Lankester, Benedicte Neven, Nizar Mahlaoui, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2023
JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective studyMarco Fischer, Peter Olbrich, Jérôme Hadjadj, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2019
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC studyFrancesca Ferrua, Stefania Galimberti, Virginie Courteille, et al.
Blood|July 1, 2020
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiencySujal Ghosh, Sevgi Köstel Bal, Emily S J Edwards, et al.
Blood|March 28, 2022
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP studyMichael H Albert, Tiarlan Sirait, Dirk-Jan Eikema, et al.
Pageof 21